SEMERGEN and ESTEVE drive the creation of a chronicity Chair together with the Catholic University of Valencia

-One of the essential objectives, along with the educational and training activities will be to promote integrated research on diseases Chronicles.

-heart failure and chronic kidney disease will be, initially, the main axes on which rotate the work teaching and research.

-La Chair will begin in April 2012once officially formalize the agreement.

Valencia, March 2012.- From next April, the Spanish society of physicians in primary care (SEMERGEN), in collaboration with ESTEVE, will create the SEMERGEN-ESTEVE Chair of chronicity, along with the Catholic University of Valencia San Vicente Mártir (UCV). This Chair is designed to promote the research, study and realization of scientific and clinical work in the area of the chronic patient care.

This cooperation agreement between the UCV and ESTEVE is has been brewing for nearly a year, and initially poses as strategic lines of research for a period of four years, from 2012 to 2016, chronic heart failure, and chronic kidney disease, both a far-reaching health problems and economic in our country.

Although still missing to formalize the agreement, with the official signing of the parties involved, the Chair is already a reality. Specifically, for this year already agreed start two theses, carried two courses on chronicity, several activities in collaboration with different public and private institutions, and submit several communications to congresses and conferences of reference as well as to participate in the master of AP (2012-2013) and create a forum for discussion (of car) sign a collaboration agreement with the University Miguel Hernández(annual character) on the model of primary care in Spain.

The Chair will undertake those training activities and publications arising from work and studies, which contribute to the development and consolidation of doctors and medical personnel. The development of these activities will be carried out through the Faculty of Medicine of the UCV.

One of the essential objectives of this chair next to the educational and training activities will be to promote research integrated on chronic diseases, ranging from basic sciences as applied and clinical aspects, trying to even create links between health professionals Spaniards and foreigners in this area. The Scientific Committee that has driven this Chair is formed by the doctors José Luis Llisterri, Rafael Micó, Vicente Pallarés, Francisco Valls and Gil Vicente.

Chart

The parties have set a structure in which an academic Board has been established and will be appointed a Director of the Chair in order to direct and encourage the development of the present Convention, as well as elaboration of the programme of activities of the Chair. This director shall have the title of Doctor, and shall be appointed by the Rector of the University, on a proposal from the Academic Board, after acceptance of the Vice President for academic planning. Will be the responsibility of the Director propose to the Board of Directors the general lines of work, as well as an annual plan containing activities to develop and the timetable for implementation; It will also be responsible for organizing and coordinating the activities of the Chair and the economic management of the same.

Focus on heart failure and kidney disease

Heart failure (CI) is a disease of far-reaching socio-health. Its poor prognosis, with high mortality rates (in some cases even exceeding some malignant tumors) and morbidity (with numerous and costly hospitalizations), as well as the progressive increase in its incidence make this pathology is one of the most important health problems today.

The role of the doctor of AP, in close coordination with the specialist in cardiology and internal medicine, is essential for proper management of the IC that allows to reduce the current morbidity and mortality of this syndrome, as well as to improve the quality of life of patients. Therefore considered that the family doctor should be increasingly involved in tackling this disease, in collaboration with professionals from other levels of care.

To try to reduce the incidence of the IC in the population and the high mortality that goes with, it is essential to know better the distribution, frequency and determinants of disease in our environment, with special attention to the causal modifiable risk factors, co-morbidity, medicalization and social situation of patients; that is why it is intended to carry out a descriptive cross-sectional and multicenter study (1st phase) and cohort (2nd phase) to answer these questions.

For its part, la enfermedad renal crónica (ERC) is a public health problem of the first magnitude in developed societies due to the progressive increase of its prevalence (especially in the terminal phase) and its linkage with a greater morbidity and mortality (above all, cardiovascular). However, the ERC is still a below-diagnosed and below-treated disease in all levels of care, which means a missed opportunity for prevention.

The proper control of the main risk factors for the ERC (diabetes, hypertension), early diagnosis and the polifarmacia are some of the main lines of work of the Chair in the scope of this disease.

About ESTEVE

ESTEVE is a leading pharmaceutical group in Spain and with a significant international presence. Since its founding in 1929, maintains a strong commitment to excellence, devoting all its efforts to promote health and improve the quality of people’s lives. ESTEVE research constitutes their main hallmark and boasts a portfolio of highly innovative projects whose final purpose is to provide answers to medical needs not covered adequately. In this sense, projects like this help to strengthen the presence of ESTEVE as partner of reference in the field of the chronicity.

About UCV

The Catholic University of Valencia San Vicente Mártir ” (UCV) was founded on 8 December 2003, fruit of the University work carried out for over fifty years by the University School of nursing “Ntra.” “Ms. de los Desamparados”, more than thirty by Edetania Foundation and more than ten by the company studies Faculty. The UCV search, at the same time, a demanding quality of University life: the joint work between faith and reason; the strengthening of a genuine University community in an atmosphere of academic friendship; and the purpose of creating and maintaining a uniquely personalized educational relationship with the University.

Spanish society of physicians in primary care (SEMERGEN)

SEMERGEN is the pioneer of primary care in Spain, with 38 years of experience. He was established with the objective of promoting the family medicine, through the maintenance and improvement of the professional competence of physicians, promoting research and facilitating the continuing education of the physician in order to maintain the quality in the care of the health of citizens.

Currently, SEMERGEN has more than ten thousand members, and is present in all professional areas, being the scientific society that brings together the most doctors work in primary care.

It has 17 regional delegations and held democratic elections every 4 years. SEMERGEN Foundation was created in 1999. This year held its thirty-fourth national Congress, as well as dozens of regional conferences. Any information on the activities organized by the society can find it www.semergen.es.